IL159280A0 - A process for preparing paroxetine hcl which limits formation of pink colored compounds - Google Patents

A process for preparing paroxetine hcl which limits formation of pink colored compounds

Info

Publication number
IL159280A0
IL159280A0 IL15928002A IL15928002A IL159280A0 IL 159280 A0 IL159280 A0 IL 159280A0 IL 15928002 A IL15928002 A IL 15928002A IL 15928002 A IL15928002 A IL 15928002A IL 159280 A0 IL159280 A0 IL 159280A0
Authority
IL
Israel
Prior art keywords
colored compounds
pink colored
paroxetine hcl
limits formation
preparing paroxetine
Prior art date
Application number
IL15928002A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL159280A0 publication Critical patent/IL159280A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15928002A 2001-06-14 2002-06-04 A process for preparing paroxetine hcl which limits formation of pink colored compounds IL159280A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29860301P 2001-06-14 2001-06-14
US32699301P 2001-10-05 2001-10-05
US34604802P 2002-01-04 2002-01-04
PCT/US2002/019016 WO2002102382A1 (en) 2001-06-14 2002-06-14 A PROCESS FOR PREPARING PAROXETINE HCl WHICH LIMITS FORMATION OF PINK COLORED COMPOUNDS

Publications (1)

Publication Number Publication Date
IL159280A0 true IL159280A0 (en) 2004-06-01

Family

ID=27404578

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15928002A IL159280A0 (en) 2001-06-14 2002-06-04 A process for preparing paroxetine hcl which limits formation of pink colored compounds

Country Status (17)

Country Link
US (1) US20030083501A1 (hu)
EP (1) EP1406625A4 (hu)
JP (1) JP2005501819A (hu)
KR (1) KR20040064615A (hu)
CN (1) CN1516585A (hu)
CA (1) CA2447808A1 (hu)
CZ (1) CZ20033574A3 (hu)
HR (1) HRP20040015A2 (hu)
HU (1) HUP0400216A2 (hu)
IL (1) IL159280A0 (hu)
IS (1) IS7074A (hu)
MX (1) MXPA03011594A (hu)
NO (1) NO20035547D0 (hu)
PL (1) PL372305A1 (hu)
SK (1) SK12004A3 (hu)
TR (1) TR200302081T2 (hu)
WO (1) WO2002102382A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777554B2 (en) * 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
AU2003271055B2 (en) * 2002-09-19 2009-03-12 Sumitomo Chemical Company, Limited Methods of crystal precipitation
DE10327517A1 (de) 2003-06-17 2005-01-13 Ht Troplast Ag Ionenleitende thermoplastische Zusammensetzungen für elektrochrome Verglasungen
WO2006113485A2 (en) * 2005-04-15 2006-10-26 Board Of Trustees Of Michigan State University Aminergic pharmaceutical compositions and methods
GB201108345D0 (en) * 2011-05-18 2011-06-29 Aesica Pharmaceuticals Ltd Process
US9254281B2 (en) * 2011-09-12 2016-02-09 Wright State University Composition and method for the treatment of neurodegeneration
CN112159398A (zh) * 2020-10-12 2021-01-01 浙江华海药业股份有限公司 一种盐酸帕罗西汀的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
EP1394160A1 (en) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Process for preparing crystalline paroxetin hydrochloride
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2187128A1 (en) * 1996-10-04 1997-06-26 K. S. Keshava Murthy New and useful polymorph of anhydrous paroxetine hydrochloride
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
EP0994872B9 (en) * 1997-06-10 2001-12-05 Synthon B.V. 4-phenylpiperidine compounds
GB9808896D0 (en) * 1998-04-25 1998-06-24 Smithkline Beecham Plc Novel compound
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
IL154422A0 (en) * 2000-08-28 2003-09-17 Synthon Bv Paroxetine compositions and processes for making the same

Also Published As

Publication number Publication date
CZ20033574A3 (cs) 2004-09-15
IS7074A (is) 2003-12-12
CN1516585A (zh) 2004-07-28
US20030083501A1 (en) 2003-05-01
PL372305A1 (en) 2005-07-11
TR200302081T2 (tr) 2004-09-21
HUP0400216A2 (hu) 2004-07-28
SK12004A3 (en) 2004-05-04
HRP20040015A2 (en) 2004-10-31
KR20040064615A (ko) 2004-07-19
EP1406625A4 (en) 2005-03-23
JP2005501819A (ja) 2005-01-20
EP1406625A1 (en) 2004-04-14
WO2002102382A1 (en) 2002-12-27
CA2447808A1 (en) 2002-12-27
NO20035547D0 (no) 2003-12-12
MXPA03011594A (es) 2005-09-08
WO2002102382A9 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
PL395097A1 (pl) Sposób wytwarzania związku o wzorze A stanowiącego pochodną tiofenu
HK1069578A1 (en) Method for preparing benzenesulfonyl compounds
GB0129611D0 (en) Process for production of styrene
PL360357A1 (en) Method for the production of a titanium-containing zeolite
IL160193A0 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
ZA200407963B (en) Method of making a finished product
IL159280A0 (en) A process for preparing paroxetine hcl which limits formation of pink colored compounds
IL159304A0 (en) Process for the production of piperidine derivatives
EP1491520A4 (en) PROCESS FOR PREPARING BISPHENOL A
PL360356A1 (en) Method for the production of a titanium-containing zeolite
IL148376A0 (en) A method for the production of pure silica
EP1547993A4 (en) PROCESS FOR PREPARING SPIROFLUORENOLS
SG108831A1 (en) Process for preventing formation of scale
EP1444263A4 (en) METHOD FOR IMPROVING THE STABILITY OF A BONE BINDING IMPLANT
TWI318971B (en) Process for production of bisphenol a
AU2002308986A1 (en) Process for preparation of a quinolinecarbaldehyde
EP1539772A4 (en) PROCESS FOR PREPARING PHOSPHORDIAMIDITE COMPOUNDS
EP1406624A4 (en) METHOD FOR PRODUCING PAROXETIN, WHICH IS ESPECIALLY FREE OF ALKOXY POLLUTION
EP1461013A4 (en) PROCESS FOR PRODUCING A NICOTINE COMPOSITION
GB0113318D0 (en) Method for production of a protein
AU2002352423A8 (en) Process for the manufacture of pharmaceutically acceptable salts of a compound
HU0101212D0 (en) Method for producing of buiding material
AU2002225426A1 (en) Process for preparation of benzylpiperidine compounds
HU0102748D0 (en) Method for producing of cemetous material
TW501419U (en) Forming mechanism for outward-turning forming machine of toecap